Chinese Academy of Medical Sciences, Fuwai Hospital

fuwaihospital.org

Total trials

143

Active

45

Phase 3

4

Total enrollment

1,306,125

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 13 of 13 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
colchicine2
Experimental: Aspirin monotherapy1
Active Comparator: Aspirin+Clopidogrel1
Experimental: Rivaroxaban monotherapy1
Active Comparator: Rivaroxaban+Clopidogrel1
FMT3
remimazolam besylate1
propofol1
Spironolactone1
RASI and/or a single pill combination based RASI1
Intensive lipid-lowering control1
Moderate-intensity lipid-lowering control1
Randomized to optimal medical therapy1

Next readouts

  • 2025-05
  • 2025-12-31
  • 2026-12-31
  • 2026-12-31
  • 2027-03-31
  • 2027-05-31
  • 2027-10-31
  • 2028-09-30
  • 2029-06

Top conditions

  • Coronary Artery Disease13
  • Hypertension8
  • COPD8
  • Coronary Heart Disease6
  • Heart Failure6
  • Hyperaldosteronism5
  • Migraine4
  • Atrial Fibrillation4

Frequently asked questions about Chinese Academy of Medical Sciences, Fuwai Hospital

How many clinical trials does Chinese Academy of Medical Sciences, Fuwai Hospital have on ClinicalTrials.gov?
Chinese Academy of Medical Sciences, Fuwai Hospital is listed as the lead sponsor on 143 clinical trials in ClinicalTrials.gov, 45 of which are currently active (recruiting, enrolling, or ongoing).
How many of Chinese Academy of Medical Sciences, Fuwai Hospital's trials are in Phase 3?
4 of Chinese Academy of Medical Sciences, Fuwai Hospital's trials are in Phase 3, spread across 13 active drug programs.
What therapeutic areas does Chinese Academy of Medical Sciences, Fuwai Hospital focus on?
Chinese Academy of Medical Sciences, Fuwai Hospital's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Hypertension, COPD, Coronary Heart Disease, Heart Failure.
When are Chinese Academy of Medical Sciences, Fuwai Hospital's next clinical trial readouts?
Chinese Academy of Medical Sciences, Fuwai Hospital has 9 upcoming primary-completion readouts tracked here; the soonest is “The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia”, expected around 2025-05.